RBC Capital Maintains Outperform on QuidelOrtho, Lowers Price Target to $68
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara maintains an Outperform rating on QuidelOrtho (NASDAQ:QDEL) but lowers the price target from $81 to $68.
May 09, 2024 | 5:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital maintains an Outperform rating on QuidelOrtho but lowers the price target from $81 to $68.
While the maintenance of an Outperform rating suggests continued confidence in QuidelOrtho's business performance and growth prospects, the reduction in the price target could reflect adjustments in market conditions, valuation concerns, or revised earnings expectations. This mixed signal might lead to short-term uncertainty among investors, potentially causing volatility in the stock's price. However, the overall positive outlook remains intact, indicating that any negative impact might be limited.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100